COMPANY
Intus Biosciences
Funding and NIH signals
- NIH award NIH awarded $404K (SBIR Phase II 1R44CA314644-01, new, notice Aug 18, 2026). NIH RePORTER 1R44CA314644-01 (Aug 18, 2026)
Evidence (1 event)
- Aug 18, 2026 · NIH RePORTER 1R44CA314644-01
Organization: INTUS BIOSCIENCES LLC; City/State: FARMINGTON, CT; Project number: 1R44CA314644-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-18; FY total cost (award amount): 404338; Administering IC: National Cancer Institute; Project title: Non-Invasive, Bacterial-Based Early-Onset Colorectal Screen; Organization type: Domestic For-Profits
- Aug 18, 2026 · NIH RePORTER 1R44CA314644-01